Supplemental Methods

Tl
+ flux assay development Tl + flux assays were performed essentially as described previously (1). Briefly, stably transfected T-Rex-HEK-293-AnKir1 cells were cultured overnight in 384-well plates in media containing DMEM, 10% dialyzed FBS and 1μg/mL tetracycline to induce channel expression ( expressing cells, the Tl + stimulus buffer contained 1.8 mM Tl 2 SO 4 . To ensure the small-molecule vehicle DMSO had no direct effect on AnKir1-dependent Tl+ flux, the assay's tolerance to different doses of DMSO was evaluated (Fig. S1B) . The robustness and reproducibility of the assay was determined by comparing Tl + flux through tetracycline-induced and tetracyclineuninduced cells (Fig. S1C) . The Z' value was calculated as described previously (1), using the following formula: were generated by screening compounds at 3-fold dilution series (1 nM -30 μM).
Tl + flux data were analyzed as previously described (2, 3) using a combination of Excel (Microsoft Corp, Redmond, WA) with XLfit add-in (IDBS, Guildford, Surrey, UK), OriginPro (OriginLab, Northampton, MA), and GraphPad Prism (GraphPad Software, San Diego, CA, USA) software. Raw data were opened in Excel and each data point in a given trace was divided by the first data point from that trace (static ratio) followed by subtraction of data points from control traces generated in presence of vehicle controls. The slope of the fluorescence increase beginning 5 s after Tl + addition and ending 15 s after Tl + addition was calculated.
Patch clamp electrophysiology
Patch electrodes were pulled from silanized 1.5 mm outer diameter borosilicate microhematocrit tubes using a P-1000 Flaming/Brown micropipette puller (Sutter Instrument, Novato CA, USA). Electrode resistance ranged from 2-4 MΩ. Whole-cell currents were recorded under voltage-clamp conditions using an Axopatch 200B amplifier (Molecular Devices, Sunnyvale, CA). Electrical connections to the amplifier were made using Ag/AgCl wires and 3 M KCl/agar bridges. Electrophysiological data were collected at 5 kHz and filtered at 1 kHz.
Data acquisition and analysis were performed using pClamp 9.2 software (Axon Instruments).
Two-electrode voltage clamp electrophysiology
Defolliculated Xenopus laevis oocytes (Ecocyte Bioscience, Asutin, TX) were injected with AeKir1 or AeKir2B cRNA (10 ng) and cultured in OR3 media for 3-7 days at 18°C.
Electrophysiology experiments were performed exactly as described previously (1, 4). The compositions of the solutions used for electrophysiology experiments are shown in Table S4 .
When present, VU041 was dissolved in solution III to a final concentration of 50 μM (0.05% DMSO). All solutions were delivered by gravity at a flow rate of ~2 ml/min to a RC-3Z oocyte chamber (Warner Instruments, Hamden, CT) using polyethylene tubing, and solution changes 
Chemical synthesis
All NMR spectra were recorded on a 400 MHz FT-NMR DRX-400 FT-NMR spectrometer or 500 MHz Bruker DRX-500 FT-NMR spectrometer. performed on a custom HP1100 purification system (reference 16) with collection triggered by mass detection. Solvents for extraction, washing and chromatography were HPLC grade. All reagents were purchased from Aldrich Chemical Co. and were used without purification.
General procedures for compound synthesis
To a solution of an amine (1 eq.) and pyridine (4 eq.) in DMF (2 mL) was added chloroacetyl chloride (1.3 eq.). After 30 min at rt, the reaction was added to a mixture of EtOAc and water (1:1). The aqueous layer was extracted with EtOAc and the organic extraction was washed with water. The organic extraction was concentrated under reduced pressure to yield the desired α-chloroacetamide.
A solution of the α-chloroacetamide (1 eq.), an amine (1 eq.) and cesium carbonate (1 eq.) in DMF was heated to 150°C for 5 min in a microwave reactor. The solution was filtered (0.45µm) and fractions were separated via reverse-phase HPLC in a gradient of MeCN in water (0.1%TFA). Fractions were combined and added to water:EtOAc (1:1) and added aq. NaHCO 3 .
The organic layer was collected and solvent was removed on air concentrator. Residue was resuspended in DCM/MeOH and filtered through phase separator into vial yielding the desired final products. 
Synthesis of 2-chloro-1-(3,4-dihydro-2H-quinolin-1-yl)ethanone (1)
To a solution of 1,2,3,4-tetrahydroquinoline (0.19 mL, 1.5 mmol) and pyridine (0.50 mL, 6.2 mmol) in DMF (2 mL) was added chloroacetyl chloride (0.16 mL, 2.0 mmol). After 30 min at rt, the reaction was added to a mixture of EtOAc and water (100mL:100mL). The aqueous layer was extracted with EtOAc (100 mL). The organic extraction was washed with water 3X (300 mL). The organic extraction was concentrated under reduced pressure to yield 1 (243 mg, 
Synthesis of 1-(3,4-dihydroquinolin-1(2H)-yl)-2-(3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)ethan-1-one (VU041)
A solution of 1 (25 mg, 0.12 mmol), 3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazole (22.7 mg, 0.12 mmol) and cesium carbonate (38.8 mg, 0.12 mmol) in DMF (1 mL) was heated to 
Lead optimization
Commercial 1,2,3,4-tetrahydroquinoline was treated with chloroacetyl chloride in the presence of pyridine to yield the 1. Next, the appropriate nitrogen heterocycle was reacted in a microwave reactor with 1 under basic conditions yielding the desired compounds. The SAR is outlined in Tables S1-S2. Our first library was designed to keep the right-hand dihydroquinoline constant and evaluate the left-hand heterocyclic portion (Table S2) . If the six-membered ring was aromatized, the compound lost activity against AnKir1, 2. Addition of a carbonyl in the 4-position of the tetrahydroindazole, 3, also led to an inactive compound. Interestingly, deletion of a nitrogen from 3 brought some activity back into 4 (12.1 mM). One compound (VU730, 5) retained its activity toward AnKir1 (IC 50 =2.4 mM), but lost activity toward Kir2.1 (IC 50 >30 mM).
Expanding the ring system to incorporate a tetrahydroquinoline retained some activity against AnKir1 (6, 8.0 mM), and deletion of the 6-membered ring of the tetrahydroisoquinoline leaving the unsubstituted pyrazole was unproductive (7, inactive). Our next library kept the left-hand trifluoromethyl tetrahydropyrazole (VU041, 1) constant while altering the right-hand amide portion of the molecule (Table S3) .
Moving from the tetrahydroquinoline to the tetrahydroisoquinoline led to an ~7-fold loss of potency (8, 15 mM). Moving to the decahydroquinoline (9, 6.7 mM) retained some activity while the regioisomer was inactive (10).
Moving to the piperidine ring was not productive (11); however, adding pendant substitution led to active compounds (phenyl, 12, 5.6 mM and dimethyl, 13, 4.5 mM). The pH of all solutions was adjusted to 7.5 with NMDG-OH. 
